SPHK1 and pulmonary fibrosis: In this study, we sought to identify key therapeutic targets within the sphingolipid metabolism pathway that contribute to the pathogenesis of lung fibrosis and to elucidate how these targets, particularly SPHK1, influence the fibrotic process through their effects on fibrocytes.